Radionuclides for radiopharmaceuticals can be produced in cyclotrons or nuclear reactors. Each of these production modes has serious issues, such as high target costs, production of long-lived wastes and contaminants, expensive separation. For this reason, new methods are under consideration for the production of highly pure radionuclides. The ISOL (Isotope Separation On-Line) method is the major technique for the production of radioactive ion beams for nuclear physics applications. The SPES-ISOLPHARM project at INFN-LNL (Istituto Nazionale di Fisica Nucleare-Laboratori Nazionali di Legnaro) is a feasibility study for the production of medical isotopes exploiting the ISOL method. The ongoing activities concerning a recent experiment focused on 111Ag, a study performed in collaboration with Padova and Trento Universities, is presented.
Radionuclides production Electromagnetic mass separation No-carrier added
This is a preview of subscription content, log in to check access.
Liu S (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radioisotopes. Adv Drug Deliv Rev 60(12):1347–1370CrossRefPubMedPubMedCentralGoogle Scholar
Nilsson T (2013) European RIB facilities—status and future. Nucl Instrum Methods Phys Res Sect B 317:194–200CrossRefGoogle Scholar
Corradetti S (2015) Thermal conductivity and emissivity measurements of uranium carbides. Nucl Instrum Methods Phys Res Sect B 360:46–53CrossRefGoogle Scholar
Manzolaro M (2010) Thermal-electric numerical simulation of a surface ion source for the production of radioactive ion beams. Nucl Instrum Methods Phys Res 623:1061–1069CrossRefGoogle Scholar
Borgna F (2017) A preliminary study for the production of high specific activity radioisotopes for nuclear medicine obtained with the isotope separation on line technique. Appl Radiat Isot 127:214–226CrossRefPubMedGoogle Scholar
Müller C (2017) Therapeutic radiometals Beyond 177Lu and 90Y: production and application of promising α-particle, β−-particle, and auger electron emitters. J Nucl Med 58:91S–96SCrossRefPubMedGoogle Scholar
Müller C (2012) A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative. J Nucl Med 53(12):1951–1959CrossRefPubMedGoogle Scholar
Mastren Y (2018) Chromatographic separation of the theranostic radioisotope 111Ag from a proton irradiated thorium matrix. Anal Chim Acta 998:75–82CrossRefPubMedGoogle Scholar